Bluejay Diagnostics, Inc. Deferred Tax Assets, Deferred Income
Bluejay Diagnostics, Inc. (BJDX) had Deferred Tax Assets, Deferred Income of $2.70 million as of 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2023-03-20
- 2022-12-31: Deferred Tax Assets, Deferred Income $2.70M.
- 2021-12-31: Deferred Tax Assets, Deferred Income $900.00K; Deferred Tax Assets, Deferred Income as first filed $937.00K.
- 2020-12-31: Deferred Tax Assets, Deferred Income $335.00K.
| Period end | Deferred Tax Assets, Deferred Income | Deferred Tax Assets, Deferred Income as first filed |
|---|---|---|
| 2022-12-31 | $2.70M 10-K · filed 2023-03-20 | |
| 2021-12-31 | $900.00K 10-K · filed 2023-03-20 | $937.00K 10-K · filed 2022-03-10 |
| 2020-12-31 | $335.00K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |